Trademarkia Logo

Canada

C$
Trademark Search in Canada
FYARRO

View On IC.GC.CA

FYARRO
ADVERTISED

on 5 Feb 2025

Last Applicant/ Owned by

AADI Bioscience, Inc.

17383 Sunset Blvd., Suite A250Pacific Palisades, CA 90272

US

Serial Number

2014713 filed on 28th Feb 2020

Correspondent Address

BORDEN LADNER GERVAIS LLP

1200 WATERFRONT CENTRE200 BURRARD STREETP.O. BOX 48600VANCOUVER

BRITISH COLUMBIA

CA

V7X1T2

FYARRO

Trademark usage description

human pharmaceutical vaccines; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, Read More

Classification Information

Class [005]
Human pharmaceutical vaccines; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations for the treatment of infectious, deficiency, hereditary, and physiological diseases, namely, for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry

Classification kind code

11

Class [042]
Medical and pharmaceutical research services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; conducting research, development, and evaluations in the field of new pharmaceuticals, namely chemical molecular analysis; pharmaceutical drug development services, namely product optimization; providing scientific research information in the fields of pharmaceuticals; clinical trial services to pharmaceutical industries; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical products; providing evaluation testing for pharmaceutical, biopharmaceutical products featuring testing for safety, toxicity, content, identity, purity, configuration and function, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases

Classification kind code

11

Mark Details

Serial Number

2014713

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 8th Jan 2025		Approved
Submitted for opposition 27
on 8th Jan 2025		Approval Notice Sent
Submitted for opposition 48
on 17th Dec 2024		Agent Changed
Submitted for opposition 15
on 26th Jul 2024		Correspondence Created
Submitted for opposition 22
on 28th Feb 2024		Search Recorded
Submitted for opposition 20
on 28th Feb 2024		Examiner's First Report
Submitted for opposition 287
on 19th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 28th Feb 2020		Filed
Submitted for opposition 1
on 28th Feb 2020		Created
Submitted for opposition 31
on 28th Feb 2020		Formalized